Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Denmark
  4. Nasdaq Copenhagen
  5. Novo Nordisk A/S
  6. News
  7. Summary
    NOVO B   DK0060534915

NOVO NORDISK A/S

(NOVO B)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

NOVO NORDISK : Bernstein gives a Buy rating

06/10/2021 | 07:49am EDT

In a research note, Bernstein analyst Wimal Kapadia has maintained his recommendation on the stock with a Buy rating. The target price is being increased from DKK 460 to DKK 500.


ę MarketScreener with dpa-AFX Analyser 2021
All news about NOVO NORDISK A/S
06/16NOVO NORDISK A/Sá : Amalgam, Novo Nordisk to Launch Dose Check Insulin Titration..
MT
06/16NOVO NORDISK A/Sá : Working With Lumen Bioscience to Evaluate Potential Strategi..
MT
06/15NOVO NORDISKá : Berenberg gives a Neutral rating
MD
06/14NOVO NORDISK A/Sá : Share repurchase programme (Form 6-K)
PU
06/10NOVO NORDISKá : Goldman Sachs keeps its Buy rating
MD
06/10NOVO NORDISKá : Bernstein gives a Buy rating
MD
06/10NOVO NORDISKá : JP Morgan keeps its Buy rating
MD
06/07NOVO NORDISK A/Sá : Share repurchase programme (Form 6-K)
PU
06/07NOVO NORDISKá : Goldman Sachs reiterates its Buy rating
MD
06/07NOVO NORDISK A/Sá : – Share repurchase programme
AQ
More news
Financials
Sales 2021 133 B 21 337 M 21 337 M
Net income 2021 44 422 M 7 118 M 7 118 M
Net cash 2021 4 605 M 738 M 738 M
P/E ratio 2021 26,8x
Yield 2021 1,88%
Capitalization 1 182 B 190 B 189 B
EV / Sales 2021 8,84x
EV / Sales 2022 8,12x
Nbr of Employees 45 157
Free-Float 69,8%
Chart NOVO NORDISK A/S
Duration : Period :
Novo Nordisk A/S Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends NOVO NORDISK A/S
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 28
Average target price 472,56 DKK
Last Close Price 514,90 DKK
Spread / Highest target 8,76%
Spread / Average Target -8,22%
Spread / Lowest Target -34,0%
EPS Revisions
Managers and Directors
NameTitle
Lars Fruergaard J°rgensen President & Chief Executive Officer
Karsten Munk Knudsen Chief Financial Officer & Executive Vice President
Helge Lund Chairman
Mads Krogsgaard Thomsen Chief Science Officer & Executive Vice President
Henrik Ehlers Wulff Executive VP & Head-Information Technology
Sector and Competitors
1st jan.Capitalization (M$)
NOVO NORDISK A/S20.68%189 536
JOHNSON & JOHNSON4.98%435 090
ROCHE HOLDING AG12.75%328 768
PFIZER, INC.7.25%220 997
NOVARTIS AG2.73%210 424
ABBVIE INC.7.23%202 939